ECM Pharmacology Congress
The Extracellular Matrix Pharmacology Congress is centered around the ECM across fibro-inflammatory diseases, revolving around target discovery and drug development, intending to cross-fertilize and assist drug development.
We focus on the live interactions and networking – the essence of both ECM2022 and ECM2024 congress experiences. We look forward to hosting you in 2026 as well!
The congress is organized by the International Society of Extracellular Matrix Pharmacology and the congress secretariat CAP Partner. Additionally, we are hosting webinars in collaboration with Nordic Bioscience to further advance ECM research.
The Congress is supported by the pharmaceutical industry, who, however, do not have influence on the scientific program.